头颈癌患者放疗不良反应监测:FACT-HN-RAD患者报告结局量表
本研究遵循美国食品药品监督管理局指南,通过文献回顾、访谈、调查和认知访谈开发了针对头颈鳞状细胞癌放疗相关不良反应的8条目FACT-HN-RAD患者报告结局量表,涵盖疼痛、吞咽困难、口干、味觉障碍、声音改变、皮炎、疲乏和体重下降,内容效度和表面效度良好,未来将评估其心理测量学效度。
要点
- FACT-HN-RAD为8条目量表,覆盖疼痛、吞咽困难、口干、味觉障碍、声音改变、皮炎、疲乏和体重下降。
- 量表开发基于文献回顾、访谈、医生调查和患者认知访谈,表面效度良好。
- 该量表可用于临床和研究中纵向监测患者报告的放疗相关不良反应及康复情况。
核心结论
- 8条目FACT-HN-RAD量表捕获了头颈鳞状细胞癌放疗最常见患者和医生报告的不良反应,可用于临床和研究环境中纵向监测患者报告的治疗相关不良反应及康复,未来将评估其心理测量学效度。
研究设计与样本
- 定性研究,遵循美国食品药品监督管理局指南开发FACT-HN-RAD量表,包括文献回顾、回顾性概念引出访谈的二次分析、执业放射肿瘤学家电子调查、现有条目映射和患者认知访谈,数据分析于2022年7月1日至2023年4月21日进行。
主要发现
- 19名概念引出访谈参与者中14名(平均年龄67岁,范围49-86岁;12名男性[86%],2名女性[14%])纳入二次分析,其中11名(79%)报告吞咽困难,8名(57%)口腔疼痛,7名(50%)口干,7名(50%)体重下降,6名(43%)皮肤灼烧感,5名(36%)味觉丧失,5名(36%)声音改变,5名(36%)疲乏。
- 9名放射肿瘤学家(平均执业时间8年,范围1-42年;5名男性[56%],4名女性[44%])报告最常见不良反应:9名(100%)报告味觉障碍,7名(78%)口干,7名(78%)黏膜炎或口腔疼痛,8名(89%)吞咽困难或吞咽痛,6名(67%)皮炎,3名(33%)疲乏。
- 10名患者(平均年龄61岁,范围29-84岁;8名男性[80%],2名女性[20%])的认知访谈显示表面效度强,全部(100%)报告量表反映了其放疗体验,并认为问卷长度「刚刚好」。
关键数值与推荐
- FACT-HN-RAD为8条目量表,涵盖疼痛、吞咽困难、口干、味觉障碍、声音改变、皮炎、疲乏和体重下降。
临床怎么用
- 该量表提供了在临床和研究环境中纵向监测患者报告的治疗相关不良反应及康复的手段。
局限性
- 未来工作将评估量表的心理测量学效度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patients undergoing radiation therapy (RT) for head and neck squamous cell carcinoma (HNSCC) experience a range of debilitating adverse effects (AEs). Patient-reported outcome (PRO) measures to quantify these AEs are a necessary and important component of health care; however, currently available PRO options often measure only disease-related symptoms or AEs of non-RT treatments. OBJECTIVE: To develop a brief PRO measure of the most common AEs associated with RT for HNSCC. DESIGN, SETTING, AND PARTICIPANTS: This was a qualitative study that followed the US Food and Drug Administration guidelines to develop a brief measure of patient-reported RT-related AEs (the Functional Assessment of Cancer Therapy-Head and Neck Radiotherapy [FACT-HN-RAD] measure). The study included (1) a literature review of clinical trials; (2) secondary analysis of retrospective concept elicitation interviews (CEIs); (3) electronic surveys of practicing radiation oncologists; (4) mapping of existing items to inform the development of the draft version of the measure; and (5) validation of content and face validity via patient cognitive interviews. Analysis was performed of CEI data and interviews with practicing radiation oncologists. Data analysis was conducted from July 1, 2022, to April 21, 2023. EXPOSURES: Surveys and qualitative interviews. MAIN OUTCOMES AND MEASURES: The most common patient-reported RT-related AEs among patients with HNSCC. RESULTS: Of 19 CEI participants, 14 (mean [range] age, 67 [49-86] years; 12 [86%] men and 2 [14%] women) described RT-related AEs and were included in the secondary analysis. Eleven (79%) patients reported difficulty swallowing; 8 (57%), oral pain; 7 (50%), dry mouth; 7 (50%), weight loss; 6 (43%), skin burning; 5 (36%), loss of taste; 5 (36%), voice changes (36%); and 5 (36%), fatigue. Nine radiation oncologists (mean [range] time in practice, 8 [1-42] years; 5 [56%] men and 4 [44%] women) reported the most common AEs: 9 (100%) reported dysgeusia; 7 (78%), xerostomia; 7 (78%), mucositis or oral pain; 8 (89%), dysphagia or odynophagia; 6 (67%), dermatitis; and 3 (33%), fatigue. Together these data informed the development of an 8-item AE-focused measure of pain, dysphagia, xerostomia, dysgeusia, voice changes, dermatitis, fatigue, and weight loss. Cognitive interviews with 10 patients (mean [range] age, 61 [29-84] years; 8 [80%] men and 2 [20%] women) demonstrated strong face validity; all (100%) reported that the measure reflected their experience with RT and stated that the length of the questionnaire was "just right." CONCLUSIONS AND RELEVANCE: The 8-item FACT-HN-RAD measure captures the most common patient- and physician-reported AEs related to RT for HNSCC. This measure offers a means to serially monitor patient-reported treatment-related AEs and recovery over time in both clinical and research settings. Future work will evaluate the psychometric validity of the measure.
引用
- Gharzai LA, Mierzwa ML, Peipert JD, et al. Monitoring Adverse Effects of Radiation Therapy in Patients With Head and Neck Cancer: The FACT-HN-RAD Patient-Reported Outcome Measure. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 37589994. doi:10.1001/jamaoto.2023.2177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。